Rethinking Clinical Trials for Pregnant and Breastfeeding Patients
Pregnant and breastfeeding individuals have long been excluded from clinical drug development, leaving physicians and patients to make critical treatment
Pregnant and breastfeeding individuals have long been excluded from clinical drug development, leaving physicians and patients to make critical treatment
FDA has issued a new gene editing guidance that gives additional information on expectations for use of next-generation sequencing. The